MicroPort Scientific Corporation (HKG:0853)
Hong Kong · Delayed Price · Currency is HKD 6.72
+0.02 (0.30%)
Jul 31, 2026, 4:08 PM HKT
MicroPort Scientific Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,105 | 1,105 | 1,031 | 950.73 | 840.83 | 778.64 |
Revenue Growth | 8.38% | 7.21% | 8.45% | 13.07% | 7.99% | 20.03% |
Gross Profit Gross Profit Growth | 634.58 | 634.58 | 574.09 | 532.1 | 501.77 | 491.77 |
Operating Income Operating Income Growth | -36.48 | -36.48 | -121.14 | -277.16 | -506.57 | -313.81 |
Net Income Net Income Growth | 48.52 | 48.52 | -214.04 | -477.63 | -436.52 | -276.48 |
Earnings Per Share EPS Growth | -0.13 | -0.13 | -0.12 | -0.27 | -0.25 | -0.17 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cardiovascular Devices Business Cardiovascular Devices Business Growth | 182.18 | 182.18 | 165.74 | - | - | - |
Orthopedics Devices Business Orthopedics Devices Business Growth | 235.16 | 235.16 | 252.71 | 238.37 | 225.34 | 215.61 |
Cardiac Rhythm Management (CRM) Business Cardiac Rhythm Management (CRM) Business Growth | 229.72 | 229.72 | 220.61 | 207.04 | 205.18 | 220.42 |
Endovascular and Peripheral Vascular Devices Business Endovascular and Peripheral Vascular Devices Business Growth | 189.48 | 189.48 | 169.54 | 168.22 | 133.27 | 106.03 |
Structural Heart Disease Business Structural Heart Disease Business Growth | 51.31 | 51.31 | 50.7 | 47.52 | 37.02 | 31.32 |
Surgical Robot Business Surgical Robot Business Growth | 77.58 | 77.58 | 36.02 | 14.81 | 3.09 | 0.33 |
Others Others Growth | 95.61 | 95.61 | 51.72 | 28.07 | 21.77 | 1.6 |
Neurovascular Devices Business - Discontinued Operation Neurovascular Devices Business - Discontinued Operation Growth | 111.04 | 111.04 | 106.98 | - | - | - |
Elimination of Intersegment Elimination of Intersegment Growth | -66.69 | -66.69 | -22.95 | -11.69 | -16.2 | - |
Total Total Growth | 1,105 | 1,105 | 1,031 | 950.73 | 840.83 | 778.64 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 791.84 | 791.84 | 827.8 | 1,131 | 1,339 | 1,820 |
Total Debt Total Debt Growth | 1,601 | 1,601 | 1,685 | 1,699 | 1,468 | 1,244 |
Net Cash (Debt) Net Cash Growth | -808.91 | -808.91 | -857.41 | -568.08 | -128.66 | 576.24 |
Net Cash Growth | - | - | - | - | - | -22.26% |
Net Cash Per Share Net Cash Per Share Growth | -0.41 | -0.41 | -0.47 | -0.31 | -0.07 | 0.32 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 69.13 | 69.13 | -49.67 | -231.87 | -343.3 | -257.53 |
Capital Expenditures CapEx Growth | -86.81 | -86.81 | -88.28 | -166.72 | -235.39 | -221.75 |
Free Cash Flow Free Cash Flow Growth | -17.68 | -17.68 | -137.95 | -398.6 | -578.7 | -479.28 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 57.41% | 57.41% | 55.68% | 55.97% | 59.68% | 63.16% |
Operating Margin | -3.30% | -3.30% | -11.75% | -29.15% | -60.25% | -40.30% |
Pretax Margin | 6.91% | 6.91% | -21.80% | -65.90% | -69.16% | -43.32% |
Profit Margin | 4.39% | 4.39% | -20.76% | -50.24% | -51.91% | -35.51% |
FCF Margin | -1.60% | -1.60% | -13.38% | -41.93% | -68.82% | -61.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.12 | 54.81 | - | - | - | - |
Forward PE | 18.88 | 97.90 | 295.11 | 295.11 | 295.11 | 295.11 |
PS Ratio | 1.50 | 2.41 | 1.47 | 2.08 | 5.71 | 8.39 |